Recent Quotes (30 days)

You have no recent quotes
chg | %

Myomo Inc  

(Public, NYSEAMERICAN:MYO)   Watch this stock  
Find more results for MYO
-0.13 (-3.21%)
Feb. 16 - Close
NYSEAMERICAN real-time data - Disclaimer
Currency in USD
Range 3.85 - 4.09
52 week 2.07 - 23.20
Open 4.03
Vol / Avg. 0.00/805,690.00
Mkt cap 23.94M
P/E     -
Div/yield     -
EPS -5.37
Shares 6.11M
Beta     -
Inst. own 13%

Key stats and ratios

Q3 (Sep. '17) 2016
Net profit margin -257.70% -327.84%
Operating margin -293.73% -296.84%
EBITD margin - -296.14%
Return on average assets -73.21% -228.41%
Return on average equity -155.42% -
CDP Score - -


One Broadway, 14Th Floor
United States - Map
+1-617-9969058 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Myomo, Inc. is a United States-based medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company’s products help to restore function in individuals with neuromuscular conditions, such as brachial plexus injury, spinal cord injury, multiple sclerosis and stroke. Its MyoPro myoelectric limb orthosis is a powered brace that supports a weakened and deformed arm for functional use. The MyoPro is an elbow/wrist/Hand orthosis, which supports the arm and helps to bend and straighten the arm at the elbow. The brace provides assistive function for joint motion that enables a user to self-initiate and control movements of a partially paralyzed arm using their own muscle signals. When the user tries to bend their arm, sensors in the brace detect the weak muscle signal, which activates the motor to amplify their weak muscle signal to help bend and move their arm. The brace uses non-invasive skin sensors.

Officers and directors

Steve Kelly Founder, Chairman of the Board, President and Chief Operating Officer
Bio & Compensation  - Reuters
Paul R. Gudonis Chief Executive Officer, Director
Bio & Compensation  - Reuters
Ralph A. Goldwasser CPA Chief Financial Officer
Bio & Compensation  - Reuters
Jonathan Naft General Manager - O&P
Bio & Compensation  - Reuters
Fredrick Nahm M.D. Ph.D. Medical Director
Bio & Compensation  - Reuters